Financials Geratherm Medical AG

Equities

GME

DE0005495626

Medical Equipment, Supplies & Distribution

Market Closed - Xetra 11:36:25 2024-04-26 am EDT 5-day change 1st Jan Change
4.08 EUR 0.00% Intraday chart for Geratherm Medical AG -0.97% -24.44%

Valuation

Fiscal Period: December 2018 2021 2022 2023 2024 2025
Capitalization 1 43.81 41.48 27.17 22.14 22.14 -
Enterprise Value (EV) 1 43.81 41.48 27.17 18.74 19.84 17.24
P/E ratio 38.5 x 419 x 25 x 15.7 x -81.6 x 19.4 x
Yield 4.52% - - 5.15% - 4.17%
Capitalization / Revenue 2.04 x - - 0.88 x 1.12 x 0.95 x
EV / Revenue 2.04 x - - 0.74 x 1 x 0.74 x
EV / EBITDA 15.6 x - - 4.07 x 13.2 x 3.83 x
EV / FCF - - - 7.21 x 198 x 6.63 x
FCF Yield - - - 13.9% 0.5% 15.1%
Price to Book 2.16 x - - 0.94 x 1 x 0.94 x
Nbr of stocks (in thousands) 4,950 4,950 5,445 5,427 5,427 -
Reference price 2 8.850 8.380 4.990 4.080 4.080 4.080
Announcement Date 4/25/19 4/26/22 6/29/23 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2021 2022 2023 2024 2025
Net sales 1 21.52 - - 25.3 19.8 23.3
EBITDA 1 2.801 - - 4.6 1.5 4.5
EBIT 1 1.987 - - 3.2 -0.3 2.4
Operating Margin 9.23% - - 12.65% -1.52% 10.3%
Earnings before Tax (EBT) 1 - - - 3 -0.5 2.1
Net income 1 1.154 0.1222 1.023 1.4 -0.3 1.2
Net margin 5.36% - - 5.53% -1.52% 5.15%
EPS 2 0.2300 0.0200 0.2000 0.2600 -0.0500 0.2100
Free Cash Flow 1 - - - 2.6 0.1 2.6
FCF margin - - - 10.28% 0.51% 11.16%
FCF Conversion (EBITDA) - - - 56.52% 6.67% 57.78%
FCF Conversion (Net income) - - - 185.71% - 216.67%
Dividend per Share 2 0.4000 - - 0.2100 - 0.1700
Announcement Date 4/25/19 4/26/22 6/29/23 - - -
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2021 2022 2023 2024 2025
Net Debt 1 - - - - - -
Net Cash position 1 - - - 3.4 2.3 4.9
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 - - - 2.6 0.1 2.6
ROE (net income / shareholders' equity) - - - 8.5% -1.7% 6.1%
ROA (Net income/ Total Assets) - - - - - -
Assets 1 - - - - - -
Book Value Per Share 2 4.110 - - 4.330 4.060 4.320
Cash Flow per Share 2 - - - 0.7200 0.1400 0.6100
Capex 1 - - - 2 1.6 1.6
Capex / Sales - - - 7.91% 8.08% 6.87%
Announcement Date 4/25/19 4/26/22 6/29/23 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
4.08 EUR
Average target price
9.15 EUR
Spread / Average Target
+124.26%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. GME Stock
  4. Financials Geratherm Medical AG